Palatin Technologies, Inc. (PTN)

NYSEAMERICAN: PTN · IEX Real-Time Price · USD
0.411 -0.003 (-0.68%)
Jan 18, 2022 3:19 PM EST - Market open
Market Cap95.06M
Revenue (ttm)259,445
Net Income (ttm)-36.77M
Shares Out231.34M
EPS (ttm)-0.16
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,543,005
Open0.425
Previous Close0.414
Day's Range0.410 - 0.433
52-Week Range0.330 - 1.300
Beta0.79
AnalystsStrong Buy
Price Target3.33 (+710.4%)
Earnings DateNov 15, 2021

About PTN

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a p...

IndustryBiotechnology
IPO DateOct 28, 1993
CEOCarl Spana
Employees26
Stock ExchangeNYSEAMERICAN
Ticker SymbolPTN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for PTN stock is "Strong Buy." The 12-month stock price forecast is 3.33, which is an increase of 710.42% from the latest price.

Price Target
$3.33
(710.42% upside)
Analyst Consensus: Strong Buy

News

Palatin to Present at H.C. Wainwright BioConnect Conference

CRANBURY, N.J., Jan. 7, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate...

1 week ago - PRNewsWire

Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out

Add these three penny stocks to your January 2022 watchlist The post Which Penny Stocks Are Investors Watching in 2022? 3 To Check Out appeared first on Penny Stocks to Buy, Picks, News and Information ...

Other symbols:OPKSENS
2 weeks ago - PennyStocks

Palatin (PTN) Begins Phase III Study For Dry Eye Disease

Palatin (PTN) commences the pivotal phase III study evaluating PL9643 for the treatment of dry eye disease. Top-line data from the same is expected in the second half of 2022.

2 weeks ago - Zacks Investment Research

Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease

CRANBURY, N.J., Dec. 28, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulat...

3 weeks ago - PRNewsWire

4 Penny Stocks To Buy For Under $1 On Webull

Cheap penny stocks to watch this week. The post 4 Penny Stocks To Buy For Under $1 On Webull appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:GTEPBTSSESN
1 month ago - PennyStocks

3 Top Penny Stocks To Watch Under $4 This Week

Are these on your penny stocks watch list this week? The post 3 Top Penny Stocks To Watch Under $4 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:RELITOMZ
1 month ago - PennyStocks

Penny Stocks To Buy For Under $1 & What To Watch Right Now

Looking for cheap penny stocks to buy? Here are 4 to watch trading below $1 right now.

Other symbols:AGRXGTEMTNB
1 month ago - PennyStocks

Keep Your Eye On Palatin Technologies as $5 Price Target Gets Attention

With several high-conviction treatments in its pipeline, Palatin Technologies is delivering results -- and PTN stock may be ready to run soon. The post Keep Your Eye On Palatin Technologies as $5 Price ...

1 month ago - InvestorPlace

Here's Why Palatin Technologies, Inc. (PTN) Is a Great 'Buy the Bottom' Stock Now

Palatin Technologies, Inc. (PTN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreem...

1 month ago - Zacks Investment Research

Hot Biotech Penny Stocks to Buy Today? 3 For Your December Watchlist

Trading biotech penny stocks right now? Check these three out The post Hot Biotech Penny Stocks to Buy Today?

Other symbols:IBIOQLGN
1 month ago - PennyStocks

Notice of Allowance Issued for Method of Treating Cytokine Storm Using Melanocortin-Specific Peptide

CRANBURY, N.J. , Nov. 30, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modula...

1 month ago - PRNewsWire

PTN Stock Alert: Why One Analyst Sees 1,371% Upside for Palatin Technologies

Palatin Technologies (PTN) stock is taking off on Wednesday thanks to an incredibly bullish new analyst price target for the shares. The post PTN Stock Alert: Why One Analyst Sees 1,371% Upside for Pala...

1 month ago - InvestorPlace

Palatin Reports First Quarter Fiscal Year 2022 Results and Provides Corporate Update

CRANBURY, N.J., Nov. 15, 2021 /PRNewswire/ -- Palatin Technologies, Inc., (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activ...

2 months ago - PRNewsWire

Palatin to Report First Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on November 15, 2021

CRANBURY, N.J., Nov. 10, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter, fiscal year 2022 operating results on Monday, November 15, 2021, before the...

2 months ago - PRNewsWire

Palatin Awarded "Top 10 Poster" Designation at the American Society of Retina Specialists (ASRS) 2021 Annual Meeting

CRANBURY, N.J., Oct. 22, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulat...

2 months ago - PRNewsWire

Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update

CRANBURY, N.J., Sept. 29, 2021 /PRNewswire/ -- Palatin Technologies, Inc., (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the acti...

3 months ago - PRNewsWire

Palatin Announces Presentation of Positive Protective Effects of PL8331 and PL9654 on Retinal Inflammation at the 202...

CRANBURY, N.J., Sept. 27, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modula...

3 months ago - PRNewsWire

Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September...

CRANBURY, N.J., Sept. 24, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2021 operating results on Wednesday, September 29, 202...

3 months ago - PRNewsWire

Palatin to Present Peptides Platform at the TIDES USA Conference

CRANBURY, N.J., Sept. 15, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modula...

4 months ago - PRNewsWire

Palatin to Participate in H.C. Wainwright 23rd Annual Global Investment Virtual Conference

CRANBURY, N.J., Sept. 13, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modula...

4 months ago - PRNewsWire

Palatin Announces Presentation at the Eyecelerator@ASCRS Conference

CRANBURY, N.J., July 22, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulat...

5 months ago - PRNewsWire

Palatin Announces Adjournment of Annual Meeting of Stockholders

CRANBURY, N.J., July 8, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) announced that its 2021 Annual Meeting of Stockholders that convened on June 8, 2021 and was adjo...

6 months ago - PRNewsWire

7 Penny Stocks For Your Watch List This Week If You Like Biotech In July

Looking for biotech penny stocks to watch right now? Here are 7 for your list this week.

6 months ago - PennyStocks

What Penny Stocks Investors Need to Know in July and 7 Stocks to Watch

What do you need to know about trading penny stocks in 2021? Here's 3 tips and 7 small-caps to watch The post What Penny Stocks Investors Need to Know in July and 7 Stocks to Watch appeared first on Pen...

Other symbols:PHUNRIGSEACSHIPUECURG
6 months ago - PennyStocks

Palatin Technologies Stock Moves Higher After Outlining Plans For Dry Eye Disease Treatment

Palatin Technologies Inc (NYSE: PTN) has completed an End-of-Phase 2 (EOP2) meeting with the FDA for PL9643 for the treatment of dry eye disease (DED). Palatin remains on track to initiate the Phase 3 p...

6 months ago - Benzinga